NDA Group will be attending PEGS Boston, that takes place in Seaport World Trade Center, Boston April 30 – May 4, 2018
NDA supported over 40% of the new medicinal products that were approved in the EU during 2013 -2017. In 2016 NDA acquired PharmApprove, the market leader in managing critical FDA interactions to help us achieve the same results in the US.
If you are planning to attend this year’s PEGS, we would really like to meet up with you. We will have a few of our experts available at the event at booth 437:
- Dr Niamh Kinsella, Biologics Expert
- Dr Jenny Sims, Non Clinical Expert
- Dr Josefin-Beate Holz, Clinical Strategy Expert
If you would like to arrange a meeting, please contact Niamh Kinsella, who will be happy to assist, firstname.lastname@example.org
Three of our experts will present at the event:
Monday 30th April 12.20 pm, Immunogenicity Case Studies and Clinical Management Track.
Title: Early Development Strategy for Bacterial- or Viral-Vectored Gene Therapies: 2 Case Studies
Monday 30th April and Tuesday 1st May, Poster Session A
Developing an Integrated Summary of Immunogenicity (ISI) to Effectively Manage Regulatory Risks in Product Development
Click here to find out more about the event.
We look forward to hearing back from you about a meeting and to seeing you at the event!